Brief: Astrazeneca Pharma India Confirms Restructuring Of Biopharmaceutical Team
30/12/2024 06:57
Dec 30 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* CONFIRMS RESTRUCTURING OF BIOPHARMACEUTICAL TEAM
* RESTRUCTURING OF BIOPHARMACEUTICAL TEAM IMPACTING CERTAIN
ROLES
Further company coverage: ASTR.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan